Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 3Recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 5Gynecologic 2Head & Neck 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Neoplasms 1Neoplasm Recurrence, Local 1Neoplasm Metastasis 1Endometrial Neoplasms 1

Interventions

Paclitaxel 81Carboplatin 67pembrolizumab 62Bevacizumab 58Cisplatin 49Specimen Handling 29Drug Therapy 26Blood Specimen Collection 23olaparib 20Cyclophosphamide 18Taxes 17Magnetic Resonance Spectroscopy 16Letrozole 16Gemcitabine 16Biopsy 16liposomal doxorubicin 15niraparib 14Brachytherapy 14fludarabine 13Radiotherapy 13abemaciclib 12Injections 12Topotecan 11Nivolumab 11Doxorubicin 11lenvatinib 10Fulvestrant 10Fluorouracil 10Surveys and Questionnaires 9Standard of Care 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × TP protocol × Gynecologic × Clear all
NCT06532539 2026-04-24

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Shandong Cancer Hospital and Institute

Phase 2 Recruiting
30 enrolled
Gynecologic

Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplasms, Endometrial Neoplasms

NCT04409860 2023-04-11

CQGOG0102

Chongqing University Cancer Hospital

Phase NA Recruiting
120 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡